David Gadiel

Senior Fellow, Health Program

David Gadiel

Expertise: Measurement and design in health care and pharmacoeconomics, economic modelling in health, and the application of economic analysis to health care delivery

David Gadiel is a double first class honours graduate in economics. He lectured in economics for 10 years at Monash and Auckland Universities and has authored more than 40 professional papers, articles and books on health and economics.

He has practised continuously as a specialised health economist since 1974. His areas of special expertise include measurement and design in health care and pharmacoeconomics, economic modelling in health, and the application of economic analysis to health care delivery.


Featured Publication

  • Towards a more competitive Medicare: The case for deregulating medical fees and co-payments in Australia 03 May 2015 | Research Report 1
    GPs have been willing to bulk bill for over 80% of GP consultations, but where local conditions permit, they are comfortable to charge patients what the market will bear. Specialists have generally opposed bulk billing, except (in some instances) for…...
    GPs have been willing to bulk bill for over 80% of GP consultations, but where local conditions permit, they are comfortable to charge patients what the market will bear. Specialists have generally opposed bulk billing, except (in some instances) for…
    READ MORE

Media & Commentary

  • 4 Corners on Medicare an economics-free zone 09 October 2015 | Ideas@TheCentre
    On 28 September ABC Television screened an episode of its 4 Corners program, hosted by Dr Norman Swan, described as a special report “on the unnecessary testing and treatments choking the health system“. No doubt this was interpreted as a…
    On 28 September ABC Television screened an episode of its 4 Corners program, hosted by Dr Norman Swan, described as a special report “on the unnecessary testing and treatments choking the health system“. No doubt this was interpreted as a…
    read more
  • A more competitive Medicare 27 March 2015
    Since the 1960s, the Commonwealth has pursued a series of wasted policies to limit out-of-pocket charges and to set with certainty what doctors charge and what patients pay in all circumstances. Since the early 1990s, it’s variously tried to anchor…
    Since the 1960s, the Commonwealth has pursued a series of wasted policies to limit out-of-pocket charges and to set with certainty what doctors charge and what patients pay in all circumstances. Since the early 1990s, it’s variously tried to anchor…
    read more
  • Doctor, charge what you dare 24 March 2015 | The Australian
    Rather than flogging the dead horse of the GP co-payment, the government could have avoided this embarrassment by leaving the responsibility of patient cost sharing to the marketplace. The current benefit for GP services is 100% of the fee specified…
    Rather than flogging the dead horse of the GP co-payment, the government could have avoided this embarrassment by leaving the responsibility of patient cost sharing to the marketplace. The current benefit for GP services is 100% of the fee specified…
    read more
  • Trans-Tasman harmonisation... a bridge too far 12 December 2014
    On 20th November 2014, Ministers for Health in Australia and New Zealand announced that work on a mutual therapeutic products regulator would cease. Although stalled on numerous occasions since negotiations commenced in 1999, this long-winded attempt at harmonising Australia's regulatory…
    On 20th November 2014, Ministers for Health in Australia and New Zealand announced that work on a mutual therapeutic products regulator would cease. Although stalled on numerous occasions since negotiations commenced in 1999, this long-winded attempt at harmonising Australia's regulatory…
    read more
  • Integrating insurance with health service provision - a volatile partnership 24 October 2014
      It is rare for a large provider of medical services to assume control of a health insurance company. But this occurred in September when Primary Health Care, a publicly-listed provider of medical and laboratory services, with a market capitalisation…
      It is rare for a large provider of medical services to assume control of a health insurance company. But this occurred in September when Primary Health Care, a publicly-listed provider of medical and laboratory services, with a market capitalisation…
    read more

Publications

  • Lessons from Singapore: Opt-Out Health Savings Accounts for Australia 28 July 2014 | PM140
    Singapore’s distinctive health funding and service provision arrangements have delivered comparable First World standards of care and health outcomes at much lower cost. A new vision for funding health in Australia based on the Singapore model could be achieved by applying the principle of choice for those who wish for…...
    Singapore’s distinctive health funding and service provision arrangements have delivered comparable First World standards of care and health outcomes at much lower cost. A new vision for funding health in Australia based on the Singapore model could be achieved by applying the principle of choice for those who wish for…
    READ MORE
  • How the NSW Coalition Should Govern Health: Strategies for Microeconomic Reform 11 July 2012 | PM128
    In an ever-tightening fiscal environment, the focus of NSW health policy must be the microeconomic reform of the rigid, public service monopoly model of public hospital care. The adoption of market or private sector methods, including greater involvement of private operators in the delivery of public health service, should be…...
    In an ever-tightening fiscal environment, the focus of NSW health policy must be the microeconomic reform of the rigid, public service monopoly model of public hospital care. The adoption of market or private sector methods, including greater involvement of private operators in the delivery of public health service, should be…
    READ MORE
  • Harmacy: The Political Economy of Community Pharmacy in Australia 10 December 2008 | PM89
    The regulatory environment that governs community pharmacy has created one of Australia’s most protected industries. It is a beneficiary of government largesse and central regulation and control in state, territory, and commonwealth jurisdictions. Entry barriers, ownership restrictions, exclusive rights to sell certain types of medicine scheduled as ‘poisons,’ and an…...
    The regulatory environment that governs community pharmacy has created one of Australia’s most protected industries. It is a beneficiary of government largesse and central regulation and control in state, territory, and commonwealth jurisdictions. Entry barriers, ownership restrictions, exclusive rights to sell certain types of medicine scheduled as ‘poisons,’ and an…
    READ MORE